Antinociceptive interactions of opioid delta receptor agonists with morphine in mice: supra- and sub-additivity.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Life Science

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0024-3205(92)90144-EPMID 1315897
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Differential antagonism of delta opioid agonists by naltrindole and its benzofuran analog (NTB) in mice: evidence for delta opioid receptor subtypes.

  1991cited by this paper
• Differential antagonism of opioid delta antinociception by [D-Ala2,Leu5,Cys6]enkephalin and naltrindole 5'-isothiocyanate: evidence for delta receptor subtypes.

  1991cited by this paper
• Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes.

  1991cited by this paper
• Modulation of the potency and efficacy of mu-mediated antinociception by delta agonists in the mouse.

  1990cited by this paper
• Naltrindole 5'-isothiocyanate: a nonequilibrium, highly selective delta opioid receptor antagonist.

  1990cited by this paper
• Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective δ agonist invivo

  1990cited by this paper
• Antinociceptive effects of [D-Ala2]deltorphin II, a highly selective delta agonist in vivo.

  1990cited by this paper
• Statistical analysis of drug-drug and site-site interactions with isobolograms.

  1989cited by this paper
• Deltorphins: a family of naturally occurring peptides with high affinity and selectivity for delta opioid binding sites.

  1989cited by this paper
• Modulation of ~-mediated antinociception by ~ agonists: characterization with antagonists

  1989cited by this paper
• Modulation of mu-mediated antinociception by delta agonists: characterization with antagonists.

  1989cited by this paper
• Opioid delta-receptor involvement in supraspinal and spinal antinociception in mice.

  1987cited by this paper
• Opioid b-receptor involvement in supraspinal and spinal antinociception in mice

  1987cited by this paper
• Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.

  1984cited by this paper
• Preparation of rat brain membranes greatly enriched with either type-I-delta or type-II-delta opiate binding sites using site directed alkylating agents: evidence for a two-site allosteric model.

  1984cited by this paper
• Bis-penicillamine enkephalins possess highly improved specificity toward delta opioid receptors.

  1983cited by this paper
• Mu and delta receptors: their role in analgesia in the differential effects of opioid peptides on analgesia.

  1982cited by this paper
• Allosteric coupling between morphine and enkephalin receptors in vitro.

  1982cited by this paper
• Opiate and peptide interaction: effect of enkephalins on morphine analgesia.

  1980cited by this paper
• Differential effects of leucine and methionine enkephalin on morphine-induced analgesia, acute tolerance and dependence.

  1979cited by this paper
• Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

  1957cited by this paper

• Subanalgesic morphine doses augment fentanyl analgesia by interacting with delta opioid receptors in male rats

  2021cites this paper
• Transcutaneous Electrical Nerve Stimulation in Patients with Cancer- Related Pain: A Systematic Review

  2019cites this paper
• Investigating the anti-cocaine, anti-nociceptive properties and side effects of MP1104, a novel mixed opioid receptor agonist

  2019cites this paper
• In vitro and in vivo activity of cyclopeptide Dmt‐c[d‐Lys‐Phe‐Asp]NH2, a mu opioid receptor agonist biased toward &bgr;‐arrestin

  2018cites this paper
• Multifunctional Opioid Ligands.

  2018cites this paper
• Opioids Resistance in Chronic Pain Management

  2017cites this paper
• Synthesis of Carfentanil Amide Opioids Using the Ugi Multicomponent Reaction.

  2015cites this paper
• Associating high intensity and modulated frequency of TENS delays analgesic tolerance in rats

  2015cites this paper
• Design and synthesis of novel bivalent ligands (MOR and DOR) by conjugation of enkephalin analogues with 4-anilidopiperidine derivatives.

  2015cites this paper
• N‐terminal guanidinylation of the cyclic 1,4‐ureido‐deltorphin analogues: the synthesis, receptor binding studies, and resistance to proteolytic digestion

  2015cites this paper
• Pharmacological Characterization of Novel Opioid Receptor Ligands Aimed at Reducing the Development of Tolerance

  2014cites this paper
• Differential antinociceptive effects of intrathecal administration of C‐terminal esterified endomorphin‐2 analogues in mice

  2014cites this paper
• Translation of structure‐activity relationships from cyclic mixed efficacy opioid peptides to linear analogues

  2014cites this paper
• Investigational peptide and peptidomimetic μ and δ opioid receptor agonists in the relief of pain

  2014cites this paper
• The delta opioid receptor

  2013cites this paper
• Synthesis, modeling, and pharmacological evaluation of UMB 425, a mixed μ agonist/δ antagonist opioid analgesic with reduced tolerance liabilities.

  2013cites this paper
• N-terminal guanidinylation of TIPP (Tyr-Tic-Phe-Phe) peptides results in major changes of the opioid activity profile.

  2013cites this paper
• Challenges for Pain Management in the Twenty-First Century

  2013cites this paper
• Mu Opioids and Their Receptors: Evolution of a Concept

  2013cites this paper
• Variation of the net charge, lipophilicity, and side chain flexibility in Dmt(1)-DALDA: Effect on Opioid Activity and Biodistribution.

  2012cites this paper
• In vivo antinociception of potent mu opioid agonist tetrapeptide analogues and comparison with a compact opioid agonist - neurokinin 1 receptor antagonist chimera

  2012cites this paper
• Preclinical assessment of drug combinations for the treatment of pain: isobolographic and dose-addition analysis of the opioidergic system.

  2011cites this paper
• Synaptic Mechanism for Functional Synergism between δ- and μ-Opioid Receptors

  2010cites this paper
• Trafficking and signaling of G protein-coupled receptors in the nervous system: implications for disease and therapy.

  2010cites this paper
• Co‐administration of &dgr;‐ and &mgr;‐opioid receptor agonists promotes peripheral opioid receptor function

  2010cites this paper
• Opioid receptor targeting ligands for pain management: a review and update

  2010cites this paper
• The determination and application of fixed-dose analgesic combinations for treating multimodal pain.

  2010cites this paper
• Design of multivalent ligand targeting G-protein-coupled receptors.

  2009cites this paper
• Modulation between high- and low-frequency transcutaneous electric nerve stimulation delays the development of analgesic tolerance in arthritic rats.

  2008cites this paper
• Interactions between drugs and occupied receptors.

  2007cites this paper
• An Overview of Drug Combination Analysis with Isobolograms

  2006cites this paper
• Opioid ligands with mixed μ/δ opioid receptor interactions: An emerging approach to novel analgesics

  2006cites this paper
• Interaction of endogenous ligands mediating antinociception.

  2006cites this paper
• Opioid ligands with mixed mu/delta opioid receptor interactions: an emerging approach to novel analgesics.

  2006cites this paper
• ,-agonist dermorphin and the 5-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and 6-opioid

  2006cites this paper
• Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance

  2005cites this paper
• Synergistic interactions between cannabinoid and opioid analgesics.

  2004cites this paper
• A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesia.

  2004cites this paper
• A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia

  2004cites this paper
• DPDPE‐UK14,304 synergy is retained in mu opioid receptor knockout mice

  2003influential citation
• Opioid interactions in rhesus monkeys: effects of delta + mu and delta + kappa agonists on schedule-controlled responding and thermal nociception.

  2003cites this paper
• Analgesic Synergy Between Topical Morphine and Butamben in Mice

  2003cites this paper
• Opioid receptor interactions: local and nonlocal, symmetric and asymmetric, physical and functional.

  2003cites this paper
• Opioid Interactions in Rhesus Monkeys: Effects of δ + μ and δ + κ Agonists on Schedule-Controlled Responding and Thermal Nociception

  2003cites this paper
• Interaction of [ D-Pen 2 , 0-PenS ] enkephalin and [ DAla 2 , Glu 4 ] deltorphin with-opioid receptor subtypes in vivo

  2002cites this paper
• Antinociceptive effects of the selective delta opioid agonist SNC80 alone and in combination with mu opioids in the squirrel monkey titration procedure

  2002cites this paper
• Drug synergism: its detection and applications.

  2001cites this paper
• Enadoline discrimination in squirrel monkeys: effects of opioid agonists and antagonists.

  2001cites this paper
• The maternal spinal cord: biochemical and physiological correlates of steroid-activated antinociceptive processes.

  2001cites this paper
• Analgesic synergy between topical lidocaine and topical opioids.

  2000cites this paper
• The Analgesic Effects of Supraspinal μ and δ Opioid Receptor Agonists Are Potentiated during Persistent Inflammation

  2000cites this paper
• Role of delta-opioid receptors in biological processes.

  2000cites this paper
• The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation.

  2000cites this paper
• Response surface analysis of synergism between morphine and clonidine.

  1999cites this paper
• Probes for narcotic receptor mediated phenomena. 26. Synthesis and biological evaluation of diarylmethylpiperazines and diarylmethylpiperidines as novel, nonpeptidic δ opioid receptor ligands

  1999cites this paper
• Probes for narcotic receptor mediated phenomena. 26. Synthesis and biological evaluation of diarylmethylpiperazines and diarylmethylpiperidines as novel, nonpeptidic delta opioid receptor ligands.

  1999cites this paper
• The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol.

  1998cites this paper
• The Enhancement of Morphine Antinociception in Mice by Δ9-Tetrahydrocannabinol

  1998cites this paper
• Gestational and ovarian sex steroid antinociception: synergy between spinal κ and δ opioid systems

  1998cites this paper
• Delta opioid receptor enhancement of mu opioid receptor-induced antinociception in spinal cord.

  1998cites this paper
• Gestational and ovarian sex steroid antinociception: synergy between spinal kappa and delta opioid systems.

  1998cites this paper
• Probes for narcotic receptor mediated phenomena. 23. Synthesis, opioid receptor binding, and bioassay of the highly selective delta agonist (+)-4-[(alpha R)-alpha-((2S,5R)-4-Allyl-2,5-dimethyl-1-piperazinyl)-3-methoxybenzyl]- N,N-diethylbenzamide (SNC 80) and related novel nonpeptide delta opioid re

  1997cites this paper
• Probes for narcotic receptor-mediated phenomena. 25. Synthesis and evaluation of N-alkyl-substituted (alpha-piperazinylbenzyl)benzamides as novel, highly selective delta opioid receptor agonists.

  1997cites this paper
• Involvement of delta 1 and delta 2 opioid receptor subtypes in the development of physical dependence on morphine in mice.

  1997cites this paper
• Involvement of δ1 and δ2 Opioid Receptor Subtypes in the Development of Physical Dependence on Morphine in Mice

  1997cites this paper
• Evolution of the Dmt-Tic pharmacophore: N-terminal methylated derivatives with extraordinary delta opioid antagonist activity.

  1997cites this paper
• Non-peptide δ opioid agonists and antagonists

  1997cites this paper
• Central & Peripheral Nervous Systems Non-peptide δ opioid agonists and antagonists

  1997cites this paper
• The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.

  1996cites this paper
• Peripheral morphine analgesia: synergy with central sites and a target of morphine tolerance.

  1996cites this paper
• Antinociceptive and behavioral effects of synthetic deltorphin analogs.

  1996cites this paper
• Role Central Mu, Delta-1, and Kappa-1 Opioid Receptors in Opioid-induced Muscle Rigidity in the Rat

  1996cites this paper
• Nitrous Oxide: Mechanism of Its Antinociceptive Action

  1995cites this paper
• Interaction between the μ‐agonist dermorphin and the δ‐agonist [D‐Ala2, Glu4]deltorphin in supraspinal antinociception and δ‐opioid receptor binding

  1995cites this paper
• Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.

  1995cites this paper
• Testing for synergism over a range of fixed ratio drug combinations: replacing the isobologram.

  1995cites this paper
• Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.

  1994cites this paper
• Activation of spinal delta-1 or delta-2 opioid receptors reduces carrageenan-induced hyperalgesia in the rat.

  1994cites this paper
• Endogenous opioids released by suspending mice by the tail selectively enhance spinal mu opioid analgesia.

  1994cites this paper
• Role of endogenous cholecystokinin in the facilitation of mu-mediated antinociception by delta-opioid agonists.

  1994cites this paper
• Dynorphin A (1-13) potentiates dynorphin A (1-17) on loss of the tail-flick reflex after intrathecal injection in the rat.

  1993cites this paper
• Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.

  1993cites this paper
• A novel delta opioid agonist, BW373U86, in squirrel monkeys responding under a schedule of shock titration.

  1993cites this paper
• Antinociceptive profile of biphalin, a dimeric enkephalin analog.

  1993cites this paper
• Evidence for delta opioid receptor subtypes in rat spinal cord: studies with intrathecal naltriben, cyclic[D-Pen2, D-Pen5] enkephalin and [D-Ala2, Glu4]deltorphin.

  1993cites this paper
• Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.

  1993cites this paper
• Antinociceptive actions of BW373U86 in the mouse.

  1993cites this paper
• Modulation of morphine antinociception by swim-stress in the mouse: involvement of supraspinal opioid delta-2 receptors.

  1993cites this paper
• Allosteric Coupling Among Opioid Receptors: Evidence for an Opioid Receptor Complex

  1993cites this paper
• Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that μ ligands are noncompetitive inhibitors of the δcx opioid peptide binding site

  1992cites this paper
• Modulation of mu-mediated antinociception in the mouse involves opioid delta-2 receptors.

  1992cites this paper
• Probing the opioid receptor complex with (+)-trans-SUPERFIT. II. Evidence that mu ligands are noncompetitive inhibitors of the delta cx opioid peptide binding site.

  1992cites this paper